---
$id: https://graph.org.ai/products/commodity/51282924
$type: Product
source: UNSPSC
code: "51282924"
title: "Ibafloxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ibafloxacin

**UNSPSC Code**: 51282924
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C15H14FNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 53VPK9R0T5, chemically known as 9-fluoro-6,7-dihydro-5,8-dimethyl-1-oxo-1h,5h-benzo(ij)quinolizine-2-carboxylic acid but generally known as ibafloxacin, which bears US NIH Compound Identifier 71186. European Medicines Agency schedules Ibafloxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08091MIG. The term IBAFLOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). IBAFLOXACIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibafloxacin under HS 29339990 and SITC 51577. As of Q4 2014, IBAFLOXACIN remains the US FDA Preferred Term for this commodity. Ibafloxacin bears US NLM identifiers UMLS ID C0098834 and NCI Concept Code C83772. SMILES: FC1C(C2CCC(N3C2C(C(=O)C(C3)C(=O)O)C1)C)C.

